|
|
||||||||
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215
| Abstract |
|---|
|
|
|---|
families and
complementarity-determining region 3 (CDR3) segments. Although the
epitope-specific CD8+ T cell response was clearly
polyclonal, a dominance of selected V
+ cell
subpopulations and clones was seen in the TCR repertoire.
Interestingly, some of the selected V
+ cell
subpopulations and clones maintained their dominance in the TCR
repertoire over time after infection with SIV of macaques. Other
V
+ cell subpopulations declined over time in their
relative representation and were replaced by newly evolving clones that
became dominant. The present study provides molecular evidence
indicating that the TCR repertoire shaped by a single viral epitope is
dominated at any point in time by selected V
+ cell
subpopulations and clones and suggests that dominant V
+
cell subpopulations and clones can either be stable or evolve during a
chronic infection. | Introduction |
|---|
|
|
|---|
Although virus-specific CTL have been extensively studied in the setting of HIV-1 infections, the TCR repertoire of CD8+ T cell responses specific for individual viral epitopes remains poorly characterized in infected individuals. To date, TCR repertoires of epitope-specific CTL have been studied by analyzing either the entire CD8+ T cell population or a limited number of CTL clones isolated from PBL of infected individuals (2, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19). Therefore, those studies have provided limited information concerning the molecular evolution of epitope-specific CD8+ T cells. Further studies of CD8+ T cell populations that recognize specific peptide/MHC class I complexes are needed to characterize the TCR repertoire of these epitope-specific CD8+ T lymphocytes.
The recent development of soluble tetrameric MHC class I/peptide complexes has allowed us to visualize and isolate epitope-specific CD8+ T cell populations from HIV-1-infected humans and SIV-infected monkeys (20, 21). This technology has facilitated an in-depth analysis of rhesus monkey CD8+ CTL specific for the dominant SIV Gag epitope p11C,C-M presented to T lymphocytes by the MHC class I allele Mamu-A*01. In a previous study, we have assessed TCR gene expression in a series of CTL clones that recognize this SIV Gag epitope (10). In the present study, we have used the tetrameric Mamu-A*01/p11C,C-M complex to characterize the TCR repertoire of this epitope-specific CD8+ T cell population and define the clonality of this immune response.
| Materials and Methods |
|---|
|
|
|---|
Rhesus monkeys (Macaca mulatta) were used in these studies. These animals were maintained in accordance with the guidelines of the Committee on Animals for Harvard Medical School and the "Guide for the Care and Use of Laboratory Animals" (National Academy Press, 1996). The rhesus monkeys were inoculated i.v. with SIV of macaques (SIVmac)3251 as described (21). All rhesus monkeys used in this study were Mamu-A*01+ as determined both by PCR-based MHC class I typing and by functional CTL assays as described previously (21).
Staining and sorting of CD8+ T cell subsets
Soluble tetrameric Mamu-A*01/p11C,C-M
complex was made as previously described (21). The
tetramer was produced by mixing biotinylated
Mamu-A*01/p11C,C-M complex with PE-labeled
streptavidin (Prozyme, San Leandro, CA) at a molar ratio of 4:1. The
PE-coupled tetrameric Mamu-A*01/p11C,C-M complex
was used in conjunction with anti-CD8
(Leu2a)-FITC (Becton
Dickinson, San Jose, CA), anti-CD8
(2ST85H7)-ECD (Beckman
Coulter, Miami, FL) and anti-rhesus monkey CD3(FN18) directly
coupled to APC. PE-coupled tetrameric
Mamu-A*01/p11C,C-M complex was used in
conjunction with the directly labeled mAbs to stain either PBMC or
single cells from lymph nodes or spleen isolated by density-gradient
centrifugation over Ficoll-Hypaque. Sorting of potentially biohazardous
specimens was performed on a Coulter EPICS Elite ESP (Beckman Coulter)
located in a dedicated BSL-3 area. The sorter was set
electronically to achieve enrichments of selected cell subsets of
>99%. As a control study, the frequency of the tetramer-staining
CD8+ T cells in uninfected animals also was
determined. In our accumulating studies, CD8+ T
cells recognizing tetrameric Mamu-A*01/p11C,CM were either
undetectable or constituted <0.1% of CD8+ T
cells in naive Mamu-A*01+ macaques.
RNA extraction and cDNA synthesis
RNA was extracted from p11C,C-M/Mamu*01
tetramer binding or nonbinding CD8+ T cell
populations according to the instructions of the RNA extraction kit
from Qiagen (Valencia, CA). cDNA was synthesized by using a method
based on the switching mechanism at the 5' end of the RNA template
(22, 23). The protocol was modified from the instructions
in the SMART cDNA Synthesis Kit from Clontech Laboratories (Palo Alto,
CA). Briefly, the cDNA reaction was catalyzed by using Moloney murine
leukemia virus reverse transcriptase (Life Technologies, Rockville,
MD), the SMART primer provided in the Clontech Kit and a modified cDNA
synthesis primer. The sequence for the modified cDNA synthesis primer
was 5'-AAGCAGTGGTAACAACGCAGAGTACT(30)NV-3'
(N = A, C,G, or T; V = A, G, or C.). The double-stranded cDNA
was made by a 10-cycle PCR with the primer and reagents provided in the
SMART cDNA synthesis kit from Clontech Laboratories. In control
experiments to validate the use of SMART cDNA synthesis in the present
studies, SMART cDNA, cDNA that was synthesized by conventional methods,
and cDNA derived from anchored PCR were all assessed for V
gene
expression (17, 24). Similar expression patterns of V
gene families were seen in these different cDNA samples (data not
shown).
TCR V
family expression
PCR-based quantitation of V
family expression was undertaken
as described previously (25). Briefly, cDNA derived from
each sample was aliquoted into 25 tubes, each containing a sense V
family-specific and an antisense C
-specific primer. As an internal
control, each reaction tube also contained a pair of primers that
amplified a 105-bp fragment of the constant region of macaque TCR
-chain. The PCR was performed for 28 cycles, with each cycle at
95°C for 30 s, 60°C for 1 min, and 72°C for 2 min. The
radiolabeled PCR products were electrophoresed through a 5%
polyacrylamide gel, dried, and exposed to x-ray film. The separated
V
-C
and C
-C
bands were measured for the radioactivity with
an Ambis 100 (Ambis, San Diego, CA) or for density by a GS-700
Densitometer (Bio-Lab, Richmond, CA). To confirm the results of
V
family expression, the identified V
families in each cDNA
sample were assessed for complementarity-determining region 3 (CDR3)
profiles through Genescan-based spectrotyping.
TCR
CDR3 profile analysis
CDR3 profiles were analyzed by Genescan-based spectrotyping
(26). cDNAs were amplified by PCR for expression
of 24 V
families by using individual V
-specific primers and a
C
-specific primer as described previously (25, 26, 27). The
second round of PCR was performed with nested V
primers and a C
primer, designed as described (26). The internal C
primer was labeled at its 5' end with the Fam fluorophore (Applied
Biosystems, Foster City, CA). The first-round PCR products were
amplified for 15 cycles under the following conditions: 95°C for
30 s, 55°C for 30 s, and 72°C for 30 s. One
microliter of each reaction product was mixed with deionized formamide
and a ROCK-500 size standard and then electrophoresed on a 5%
acrylamide gel on a 377 DNA sequencer (Applied Biosystems). Data were
analyzed for size and fluorescence intensity by using the Genescan
software (Applied Biosystems). Experiments performed on samples
obtained at three different times from four normal monkeys indicated
that these CDR3 length analyses were highly reproducible and
V
-specific. Further cloning and sequencing in conjunction with the
CDR3 length display allowed the prediction of CDR3 lengths. These
lengths were expressed as predicted numbers of amino acids.
Sequencing and frequency analyses of TCR
cDNA clones isolated
from the tetramer-binding CD8+ T cells
The nonselective cloning and sequencing of TCR
cDNA were
done by using a technique modified from the anchored PCR, as described
previously (24). The TCR
cDNA was isolated from the
SMART cDNA with the SMART primer (Clontech Laboratories) containing an
EcoRI site and a C
primer containing an XbaI
site. The PCR was performed for 30 cycles under the following
conditions: 95°C for 30 s, 60°C for 1 min, and 72°C for 2
min. The PCR products were digested with EcoRI and
XbaI and ligated into the pSP65 plasmid (Promega, Madison,
WI) for cloning and sequencing (2). For frequency
analyses, 80120 clones were sequenced and analyzed for each cDNA
sample. The frequency of the individual clones was determined based on
the percentage of each clone in the total clones isolated from each
cDNA sample.
| Results |
|---|
|
|
|---|
repertoire in CD8+ T
cell populations that recognize the tetrameric
Mamu-A*01/p11C,CM complex
To directly examine the TCR repertoire of a single viral
epitope-specific CD8+ T cell population during an
AIDS virus infection, tetrameric
Mamu-A*01/p11C,C-M complex-binding
CD8+ T cell populations from SIVmac-infected,
Mamu-A*01+ rhesus monkeys were isolated and
assessed for their expression of 24 V
gene families. The
CD8+ T cell populations recognizing this
tetrameric Mamu-A*01/p11C,C-M complex were
detectable in PBL of acutely and chronically SIVmac-infected monkeys
(Fig. 1
). The tetrameric
Mamu-A*01/p11C,CM complex-bound CD8+
T cells were isolated by flow cytometric sorting and assessed for their
TCR V
repertoire. A limited diversity of TCR V
gene usage was
seen in the tetrameric Mamu-A*01/p11C,C-M
complex-bound CD8+ T cell populations. The
tetrameric Mamu-A*01/p11C,CM complex-bound
CD8+ T cell populations predominantely expressed
TCR with certain V
gene family members (Fig. 2
). Interestingly, a V
13-expressing
cell subpopulation was consistently dominant in the tetrameric
Mamu-A*01/p11C,C-M complex-bound
CD8+ T cell populations from the monkeys
examined. The V
13-expressing cell populations constituted from 17 to
48% of the tetramer+ CD8+
T cell populations sorted from the PBL of the SIVmac-infected monkeys
(Fig. 2
). In contrast, the CD8+ T cell
populations derived from the PBL of the same monkeys that did not bind
to tetrameric Mamu-A*01/p11C,CM complex exhibited a diverse
TCR V
repertoire. All 24 V
families were expressed in these
tetramer-negative cell populations (Fig. 2
). Therefore, these results
suggested that the tetrameric Mamu-A*01/p11C,C-M
complex interacted with only selected CD8+ T cell
subpopulations.
|
|
+CD8+ T
cell populations that recognize tetrameric
Mamu-A*01/p11C,CM complex
To determine whether the CD8+ T cells
that recognize this single SIV Gag epitope are restricted in the CDR3
regions they use, we examined the CDR3 profiles of selected
V
-expressing cell subpopulations in the tetrameric
Mamu-A*01/p11C,C-M complex-bound
CD8+ T cell population. CDR3 spectrotyping
analysis revealed a restricted pattern of CDR3 profiles in the selected
V
-expressing CD8+ T cell subpopulations that
recognize the tetrameric Mamu-A*01/p11C,C-M
complex. A CDR3 of a single length was identified in the majority of
these selected V
-expressing CD8+ T cell
subpopulations, whereas the CD8+ T cells that did
not bind the tetramer displayed multiple CDR3 lengths (Fig. 3
). A CDR3 length of 11 aa appeared to be
the most frequently used by the selected
V
+CD8+ T cell
subpopulations in the tetramer-bound lymphocytes (Fig. 3
). These
results extend the studies of V
family expression described above
and demonstrate at a CDR3 level the limited diversity of TCR repertoire
in the CD8+ T cell subpopulations that bind to
the tetrameric Mamu-A*01/p11C,C-M complex.
|
+CD8+ T cell
populations that recognize tetrameric Mamu-A*01/p11C,CM
complex
As a complementary study, sequencing of TCR
cDNA was
used to characterize the TCR repertoire and clonality of the
CD8+ T cell population that binds to the
tetrameric Mamu-A*01/p11C,C-M complex. These
sequence analyses yielded results similar to those shown in the
PCR-based quantitation of V
gene family expression and the CDR3
profile studies. A predominant use of the sellected V
gene families
was seen at the sequence level in the CD8+ T cell
population that bound to the tetrameric
Mamu-A*01/p11C,C-M complex (Figs. 2
and 4
, A and
B). These selected
V
+CD8+ T cell
subpopulations exhibited monoclonal or oligoclonal dominance and
restricted CDR3 lengths. Nevertheless, the CD8+ T
cell populations recognizing the tetrameric
Mamu-A*01/p11C,C-M complex were clearly
polyclonal (Fig. 4
). Furthermore, the number of dominant clones in the
CD8+ T cell populations that bound the tetrameric
Mamu-A*01/p11C,C-M complex appeared to be
smaller during the chronic than during the acute phase of SIVmac
infection (Fig. 4
, A and B). These results
provide further evidence that SIVmac-infected Mamu
A*01+ rhesus monkeys develop a p11C-specific
CD8+ T cell response comprised of limited numbers
of V
-expressing cell subpopulations.
|
+ cell subpopulations or clones in the
p11C-specific CD8+ T cell population can change during the
course of SIVmac infections
Finally, we sought to examine the temporal evolution of the TCR
repertoire of the CD8+ T cell populations that
recognize the tetrameric Mamu-A*01/p11C,C-M
complex. Cells that bound to the tetrameric
Mamu-A*01/p11C,C-M complex were isolated by
sorting PBL of two Mamu-A*01+ rhesus monkeys 0.5,
2, and 7 mo after SIVmac infection (Fig. 5
). Although some selected
V
+CD8+ T cell
subpopulations maintained their clonal dominance over time, others
fluctuated in their clonal representation in the TCR repertoire. These
varied patterns of clonal evolution were seen at both the level of V
family expression and CDR3 profiles during the 7-mo follow-up of the
SIVmac-infected monkeys (Figs. 6
and 7
). Some of the clones identified in PBL
during the period of acute infection maintained their dominance in the
repertoire of the tetramer-binding CD8+ T cell
populations, whereas others were either lost or decreased in the
frequency of their representation within this cell population (Fig. 8
). Interestingly, those clones that lost
their dominance over time appeared to be replaced by newly evolving
clones that became dominant during chronic SIVmac infection (Fig. 8
).
Therefore, these results provide molecular evidence that dominant
V
+ cell subpopulations or clones in the
repertoire of the p11C-specific CD8+ T cell
population can be stable or changing during the course of SIVmac
infections.
|
|
|
|
| Discussion |
|---|
|
|
|---|
gene usage in cells
that had not been manipulated in vitro. Moreover, this approach allowed
us to characterize TCR V
gene usage in larger numbers of cells than
had been studied in the earlier experiments. The earlier experiments
showed that p11C-specific CTL clones can be restricted predominately to
T cell subpopulations expressing members of the V
6 or V
13 family
of genes (10). In fact, the V
families used by those
CTL clones were dominant within the TCR V
repertoire identified in
the present study in the CD8+ T cell population
recognizing the Mamu-A*01/p11C,CM complex. However, T cell
subpopulations expressing V
families other than V
6 and V
13
also were identified in the CD8+ T cell
population recognizing the Mamu-A*01/p11C,C-M
complex. Therefore, the results of the present study complement these
earlier studies, demonstrating the broad TCR repertoire shaped by the
Mamu-A*01/p11C,CM complex during SIVmac infection.
The patterns of V
dominance in the
Mamu-A*01/p11C,C-M tetramer-binding
CD8+ T cell populations varied among individual
SIVmac-infected monkeys. The differences among the monkeys is unlikely
to be a result of biases introduced by the molecular analyses
themselves, because differing patterns of V
family usage were
confirmed by PCR amplification with primers that encompass all of the
identified V
families and known clonotypic sequences (see
Materials and Methods; data not shown). Moreover,
variability in the patterns of dominance of selected V
families in
different monkeys also was seen in our previous study of
epitope-specific CTL clones (10, 24). This variability
also cannot be explained by the existence of multiple subtypes of the
Mamu-A*01 allele, where each subtype might select for a different
V
+CD8+ T cell
subpopulation, because sequencing of the
2 domain of the Mamu-A*01
allele from >600 animals has demonstrated no polymorphism in that gene
in Indian rhesus moneys (data not shown). It is likely that the
variation in V
dominance reflects the differences in thymic
selection driven by the complexity of MHC haplotypes in outbred species
(28). We also cannot exclude the possibility that
differences in cytokine profiles among the infected monkeys may
contribute to the distinct V
patterns seen in individual animals
(29).
The present study provides molecular evidence that some of the dominant
V
+ cell subpopulations or clones in the
p11C-specific CD8+ T cell population can be
stable over time during the course of SIVmac infections. These results
are consistent with a recent report describing the persistence of a
peptide epitope-specific CTL clone in an HIV-1-infected person
(11, 30, 31). The stability of at least a portion of the
repertoire of SIVmac p11C-specific CD8+ T cell
populations suggests that viral peptide epitope-specific
CD8+ T cell clones can continuously proliferate
and expand in AIDS virus-infected individuals. Such prolonged
expansions of dominant clones may provide an advantage in containing
persistent viral replication in infected individuals.
Others of the dominant V
+ cell subpopulations
or clones in the p11C-specific CD8+ T cell
population appear to vary during the course of SIVmac infections. These
changes in the TCR repertoire do not appear to be driven by the
emergence of viral mutants, as we were unable to identify a high
frequency of mutations in the epitope-coding region of SIVmac
gag during the 7-mo follow-up of monkeys 9398 and 9498 (data
not shown). Rather, the evolving clonal dominance in the TCR repertoire
over time may be driven by host factors, some of which may be
consequences of the SIV infection itself. Thus, for example, a burst of
viral replication and an associated marked depletion of
CD4+ T cells occur during the period of primary
SIVmac infection in monkeys. This high viral load and sharp decline in
CD4+ T helper cells may affect the proliferation
or turn-over of specific CD8+ T lymphocyte
clones. These viral and immune changes may, in turn, affect the TCR
repertoire of the CD8+ virus-specific CTL. As a
result, some clones that are present during primary infection may be
replaced by others that emerge during the chronic phase of infection.
It is also possible that changes in production of specific cytokines as
described above may select for dominant clones in the TCR repertoire
during SIV infection of a monkey. Finally, we cannot exclude the
possibility that random selection may underlie the changes in clonal
dominance in the TCR repertoire of the CD8+ T
cell population recognizing the
Mamu-A*01/p11C,C-M complex. By whatever
mechanism, the results of the present study suggest that some
V
+ populations or clones that emerge in the
chronically infected monkey can replace previously dominant cell
subpopulations in the repertoire of the p11C-specific
CD8+ T cell response during SIVmac
infections.
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Zheng W. Chen, 330 Brookline Avenue, RE113, Boston, MA 02215. ![]()
3 Abbreviations used in this paper: SIVmac, SIV of macaques; CDR3, complementarity-determining region 3. ![]()
Received for publication November 7, 2000. Accepted for publication January 19, 2001.
| References |
|---|
|
|
|---|
repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric of simian-human immunodeficiency virus. J. Exp. Med. 182:21.
usage during the primary immune response to HIV. Nature 370:463.[Medline]
4 and V
10 T cell receptor genes by
lymphocytic choriomeningitis virus glycoprotein-specific
H-2Db-restricted cytotoxic T cells. Eur. J. Immunol.
20:523.
and
chains of human T cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 88:8987.
17 gene segment. J. Exp. Med.; 181:79.
gene family in SIV gag-specific cytotoxic T lymphocytes in rhesus monkey. J. Virol. 66:3913.
T cell receptors. Curr. Opin. Immunol. 9:250.[Medline]
This article has been cited by other articles:
![]() |
H. Wei, D. Huang, X. Lai, M. Chen, W. Zhong, R. Wang, and Z. W. Chen Definition of APC Presentation of Phosphoantigen (E)-4-Hydroxy-3-methyl-but-2-enyl Pyrophosphate to V{gamma}2V{delta}2 TCR J. Immunol., October 1, 2008; 181(7): 4798 - 4806. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Venturi, H. Y. Chin, D. A. Price, D. C. Douek, and M. P. Davenport The Role of Production Frequency in the Sharing of Simian Immunodeficiency Virus-Specific CD8+ TCRs between Macaques J. Immunol., August 15, 2008; 181(4): 2597 - 2609. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, T. Dong, E. Turnbull, S. Ranasinghe, B. Ondondo, N. Goonetilleke, N. Winstone, K. di Gleria, P. Bowness, C. Conlon, et al. Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy J. Immunol., July 1, 2007; 179(1): 597 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Loffredo, B. J. Burwitz, E. G. Rakasz, S. P. Spencer, J. J. Stephany, J. P. Giraldo Vela, S. R. Martin, J. Reed, S. M. Piaskowski, J. Furlott, et al. The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape J. Virol., March 15, 2007; 81(6): 2624 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hasegawa, C. Moriya, H. Liu, W. A. Charini, H. C. Vinet, R. A. Subbramanian, P. Sen, N. L. Letvin, and M. J. Kuroda Analysis of TCR{alpha}beta Combinations used by Simian Immunodeficiency Virus-Specific CD8+ T Cells in Rhesus Monkeys: Implications for CTL Immunodominance J. Immunol., March 15, 2007; 178(6): 3409 - 3417. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chung, W. Lee, J. T. Loffredo, B. Burwitz, T. C. Friedrich, J. P. Giraldo Vela, G. Napoe, E. G. Rakasz, N. A. Wilson, D. B. Allison, et al. Not All Cytokine-Producing CD8+ T Cells Suppress Simian Immunodeficiency Virus Replication J. Virol., February 1, 2007; 81(3): 1517 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Messaoudi, J. Warner, M. Fischer, B. Park, B. Hill, J. Mattison, M. A. Lane, G. S. Roth, D. K. Ingram, L. J. Picker, et al. From the Cover: Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates PNAS, December 19, 2006; 103(51): 19448 - 19453. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Manuel, W. A. Charini, P. Sen, F. W. Peyerl, M. J. Kuroda, J. E. Schmitz, P. Autissier, D. A. Sheeter, B. E. Torbett, and N. L. Letvin Contribution of T-Cell Receptor Repertoire Breadth to the Dominance of Epitope-Specific CD8+ T-Lymphocyte Responses J. Virol., December 15, 2006; 80(24): 12032 - 12040. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singh and Y. Paterson Vaccination Strategy Determines the Emergence and Dominance of CD8+ T-Cell Epitopes in a FVB/N Rat HER-2/neu Mouse Model of Breast Cancer. Cancer Res., August 1, 2006; 66(15): 7748 - 7757. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Turnbull, A. R. Lopes, N. A. Jones, D. Cornforth, P. Newton, D. Aldam, P. Pellegrino, J. Turner, I. Williams, C. M. Wilson, et al. HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently J. Immunol., May 15, 2006; 176(10): 6130 - 6146. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meyer-Olson, K. W. Brady, M. T. Bartman, K. M. O'Sullivan, B. C. Simons, J. A. Conrad, C. B. Duncan, S. Lorey, A. Siddique, R. Draenert, et al. Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire Blood, March 15, 2006; 107(6): 2373 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dong, G. Stewart-Jones, N. Chen, P. Easterbrook, X. Xu, L. Papagno, V. Appay, M. Weekes, C. Conlon, C. Spina, et al. HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor J. Exp. Med., December 20, 2004; 200(12): 1547 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meyer-Olson, N. H. Shoukry, K. W. Brady, H. Kim, D. P. Olson, K. Hartman, A. K. Shintani, C. M. Walker, and S. A. Kalams Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape J. Exp. Med., August 2, 2004; 200(3): 307 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Lopes, A. Jaye, L. Dorrell, S. Sabally, A. Alabi, N. A. Jones, D. R. Flower, A. De Groot, P. Newton, R. M. Lascar, et al. Greater CD8+ TCR Heterogeneity and Functional Flexibility in HIV-2 Compared to HIV-1 Infection J. Immunol., July 1, 2003; 171(1): 307 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boissonnas, O. Bonduelle, A. Antzack, Y.-C. Lone, C. Gache, P. Debre, B. Autran, and B. Combadiere In Vivo Priming Of HIV-Specific CTLs Determines Selective Cross-Reactive Immune Responses Against Poorly Immunogenic HIV-Natural Variants J. Immunol., October 1, 2002; 169(7): 3694 - 3699. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Valmori, V. Dutoit, V. Schnuriger, A.-L. Quiquerez, M. J. Pittet, P. Guillaume, V. Rubio-Godoy, P. R. Walker, D. Rimoldi, D. Lienard, et al. Vaccination with a Melan-A Peptide Selects an Oligoclonal T Cell Population with Increased Functional Avidity and Tumor Reactivity J. Immunol., April 15, 2002; 168(8): 4231 - 4240. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Douek, M. R. Betts, J. M. Brenchley, B. J. Hill, D. R. Ambrozak, K.-L. Ngai, N. J. Karandikar, J. P. Casazza, and R. A. Koup A Novel Approach to the Analysis of Specificity, Clonality, and Frequency of HIV-Specific T Cell Responses Reveals a Potential Mechanism for Control of Viral Escape J. Immunol., March 15, 2002; 168(6): 3099 - 3104. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. McKay, J. E. Schmitz, D. H. Barouch, M. J. Kuroda, M. A. Lifton, C. E. Nickerson, D. A. Gorgone, and N. L. Letvin Vaccine Protection Against Functional CTL Abnormalities in Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys J. Immunol., January 1, 2002; 168(1): 332 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Bitmansour, S. L. Waldrop, C. J. Pitcher, E. Khatamzas, F. Kern, V. C. Maino, and L. J. Picker Clonotypic Structure of the Human CD4+ Memory T Cell Response to Cytomegalovirus J. Immunol., August 1, 2001; 167(3): 1151 - 1163. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |